Indivior Pharmaceuticals (INDV) Earnings Date & Reports

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

INDV is expected to report earnings to fall 30.22% to 80 cents per share on October 29

Indivior Pharmaceuticals INDV Stock Earnings Reports

Q3'26

Est.

$0.80

Q2'26

Beat

by $0.41

Q1'26

Beat

by $0.30

Q4'25

Beat

by $0.15

Q3'25

Beat

by $0.33

The last earnings report on August 03 showed earnings per share of $1.15, beating the estimate of 74 cents. With 628.62K shares outstanding, the current market capitalization sits at 4.23B.

View a ticker or compare two or three

INDV

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for INDV